FINDINGS:
Comparison: 2023-09-30.
Pulmonary parenchyma: Clear lungs without focal mass. No suspicious nodules identified.
Mediastinum: Cardiomediastinal contours within normal limits.
Pleura/Pleural spaces: No pleural effusion or pleural thickening. no pleural nodularity.
Great vessels/Aorta: No thoracic aortic aneurysm or dissection.
Liver: No focal hepatic lesions. Normal attenuation.
Spleen: Normal in size and attenuation. No focal splenic lesion.
Pancreas: Normal pancreatic contour and enhancement. No focal mass. no pancreatic mass.
Adrenal glands: Adrenal glands are normal without nodules. adrenal glands normal.
Kidneys: 61 mm spiculated enhancing renal mass in the left kidney, interpolar. No hydronephrosis. No enhancing renal mass. Bosniak I cyst. no renal mass. Postsurgical change: resection margin changes.
GI tract/Bowel: No obstructive process. No focal bowel wall mass identified.
Mesentery/Omentum: 27 mm lesion in the peritoneum, suspicious for metastasis. No ascites. No omental caking. no peritoneal nodularity.
Mesenteric vessels (SMA/SMV): SMA/SMV are patent without thrombosis.
Urinary bladder: Unremarkable.
Reproductive organs: No adnexal mass. Uterus/prostate within expected size for age. calcifications.
Lymph nodes: Enlarged mesenteric lymph node, short axis 3.6 cm. No pathologically enlarged lymph nodes by size criteria.
Bones/Osseous structures: No aggressive osseous lesion. No acute fracture. bone islands.

IMPRESSION:
- Kidney primary malignancy at left kidney, interpolar measuring approximately 61 mm.
- Findings concerning for nodal involvement.
- Findings compatible with distant metastases involving: peritoneum.
- RECIST 1.1 Summary:
- Target lesions (n=3; ≤2 per organ rule applied).
  • T1: Primary — 48→61 mm (longest diameter).
  • T2: Metastasis — 21→27 mm (longest diameter).
  • T3: Lymph node — 27→36 mm (short axis).
- SLD baseline: 96 mm.
- SLD current: 124 mm (+29.2% change).
- New lesions: absent (unequivocal).
- - RECIST 1.1 overall response category: PD.
